Sweden’s AstraZeneca invests $220 million in Vietnam
By Nha Nam
May 30, 2019 | 01:10 PM GMT+7
The Swedish biopharmaceutical company has pledged to invest some $220 million in Vietnam’s healthcare sector in the 2020-2024 period.
The biopharmaceutical company looks set to improve the healthcare products and services to Vietnamese.
AstraZeneca has announced its five-year investment plan worth of $220 million in Vietnam.
The committed fund is said to help the biopharmaceutical giant further develop and enhance the quality of healthcare products and services to Vietnamese patients.
The company will also provide hundreds of jobs in the fields of biomedical and medical sciences, as well as medical sales and marketing through its partnerships with other businesses.
Part of AstraZeneca’s commitment includes the implementation of the Young Health Programme to improve the management and control of non-communicable diseases.
Accordingly, AstraZeneca, Plan International, the National Youth Centre and the Hanoi Centre for Disease Prevention and Control will work together to empower young people and their communities to make healthy choices in diet, exercise and lifestyle.
According to Leif Johannson, chairman of AstraZeneca, its investment in Vietnam will help lift the country’s healthcare capability to world-class levels and reach the goals of the UN 2030 Agenda for Sustainable Development.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas of oncology, cardiovascular, renal and metabolism and respiratory.
Measures to improve medical check-ups and treatment, along with State management of drug prices and provisions at medical facilities and investment in grassroots healthcare to reduce overloading at central hospitals were among issues addressed by Minister of Health, Nguyen Thi Kim Tien at a Q&A session of the National Assembly of Vietnam yesterday.
Measures to improve medical check-ups and treatment, along with State management of drug prices and provisions at medical facilities and investment in grassroots healthcare to reduce overloading at central hospitals were among issues addressed by Minister of Health, Nguyen Thi Kim Tien at a Q&A session of the National Assembly of Vietnam yesterday.
Menas Group has entered a strategic partnership with Keppel to co-develop an integrated ecosystem of lifestyle services across Keppel’s real estate projects in Vietnam, beginning with the landmark Celesta City development in Saigon South.
PVI Asset Management (PVI AM) and SonKim Capital (SK Capital), a business unit of SonKim Group has announced a strategic collaboration to develop innovative real estate investment products tailored for institutional investors and high-net-worth individuals.
Filum AI has successfully raised $1 million in funding despite a challenging venture capital market, underscoring the potential of AI and shifting investment strategies.
Enterprises are advised to promptly assess and evaluate the impact of the changes in the newly-issued to ensure timely compliance in the upcoming tax finalization period.
